{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:42:35Z","timestamp":1786995755349,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pnpbp.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T10:19:18Z","timestamp":1465985958000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Elevated levels of circulating thyroid hormone do not cause the medical sequelae of hyperthyroidism"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8805-975X","authenticated-orcid":false,"given":"Tammas","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Denmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Z.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2016.06.001_bb0005","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.25011\/cim.v35i3.16591","article-title":"Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer","volume":"35","author":"Abonowara","year":"2012","journal-title":"Clin. Investig. Med."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archpsyc.1990.01810170035006","article-title":"Rapid cycling bipolar affective disorder: II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study","volume":"47","author":"Bauer","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/15622970109027495","article-title":"Thyroid hormone, neural tissue and mood modulation","volume":"2","author":"Bauer","year":"2001","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(97)00181-4","article-title":"Treatment of refractory depression with high-dose thyroxine","volume":"18","author":"Bauer","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0030","first-page":"49","article-title":"Clinical applications of levothyroxine in refractory mood disorders","volume":"2","author":"Bauer","year":"2003","journal-title":"Clin. Appl. Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/sj.mp.4001647","article-title":"Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression","volume":"10","author":"Bauer","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0040","article-title":"Levothyroxine effects on depressive symptoms and limbic glucose metabolism in bipolar disorder: a randomized, placebo-controlled positron emission tomography study","author":"Bauer","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0045","series-title":"Subclinical Hyperthyroidism of Variable Etiology and its Influence on Bone in Postmenopausal Women. HORMONES-ATHENS-6, 62","author":"Belaya","year":"2007"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","article-title":"Mechanisms in endocrinology: heart failure and thyroid dysfunction","volume":"167","author":"Biondi","year":"2012","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2010.105","article-title":"Cardiovascular involvement in patients with different causes of hyperthyroidism","volume":"6","author":"Biondi","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-11-0299","article-title":"A critical review and meta-analysis of the association between overt hyperthyroidism and mortality","volume":"165","author":"Brandt","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0070","series-title":"Texas Medication Algorithm Project Procedural Manual, Bipolar Disorder Algorithms","author":"Crismon","year":"2007"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1006\/bbrc.1995.1831","article-title":"Evidence for the presence of functional thyrotropin receptor in cardiac muscle","volume":"211","author":"Drvota","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0080","first-page":"160","article-title":"The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment","volume":"11","author":"Eftekhari","year":"2008","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/clc.4960230605","article-title":"Hyperthyroid heart disease","volume":"23","author":"Fadel","year":"2000","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/rp.59.1.31","article-title":"Effects of thyroid hormone on the cardiovascular system","volume":"59","author":"Fazio","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0095","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.2012-3080","article-title":"Update in TSH receptor agonists and antagonists","volume":"97","author":"Gershengorn","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0100","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0006-3223(96)00472-6","article-title":"Bone mineral density and l-thyroxine treatment in rapidly cycling bipolar disorder","volume":"41","author":"Gyulai","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-0327(00)00306-2","article-title":"Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term l-thyroxine augmentation","volume":"66","author":"Gyulai","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1089\/thy.2006.16.583","article-title":"The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma","volume":"16","author":"Heemstra","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0120","article-title":"Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study","author":"Hesselink","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0125","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.2188\/jea.JE20090224","article-title":"Calcium intake and associated factors in a general Japanese population: baseline data of NIPPON DATA80\/90 and the National Nutrition Survey","volume":"20","author":"Higashiguchi","year":"2009","journal-title":"J. Epidemiol. Jpn. Epidemiol. Assoc."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0130","article-title":"Guideline watch: practice guideline for the treatment of patients with bipolar disorder, APA Practice Guidelines","author":"Hirschfeld","year":"2010","journal-title":"Am. Psychiatr. Assoc."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s001980050069","article-title":"Bone changes in pre-and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass","volume":"8","author":"Jodar","year":"1998","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0140","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","article-title":"Outcomes of patients with differentiated thyroid carcinoma following initial therapy","volume":"16","author":"Jonklaas","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2014.04.022","article-title":"A favorable risk-benefit analysis of high dose thyroid for treatment of bipolar disorders with regard to osteoporosis","author":"Kelly","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2015.01.016","article-title":"An examination of myth: a favorable cardiovascular risk-benefit analysis of high-dose thyroid for affective disorders","volume":"177","author":"Kelly","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0155","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0160","first-page":"1232","article-title":"Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin","volume":"81","author":"Kung","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00223-002-0027-8","article-title":"Thyroid hormones: beneficial or deleterious for bone?","volume":"73","author":"Lakatos","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1677\/erc.1.00892","article-title":"Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis","volume":"12","author":"Links","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0180","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dom\u00ednguez","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer","volume":"81","author":"Perros","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jso.10043","article-title":"Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature","volume":"79","author":"Quan","year":"2002","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0195","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jad.2011.06.011","article-title":"Long-term treatment with supraphysiological doses of thyroid hormone in affective disorders\u2014effects on bone mineral density","volume":"136","author":"Ricken","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0200","first-page":"1","article-title":"The expert consensus guideline series: medication treatment of bipolar disorder","volume":"1","author":"Sachs","year":"2000","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0210","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.surg.2011.09.013","article-title":"Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study","volume":"150","author":"Sugitani","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0215","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1056\/NEJMcp010145","article-title":"Subclinical hyperthyroidism","volume":"345","author":"Toft","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0220","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5694\/j.1326-5377.2004.tb05866.x","article-title":"5: diagnosis and management of hyperthyroidism and hypothyroidism","volume":"180","author":"Topliss","year":"2004","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MAJ.0b013e31821790f4","article-title":"Hyperthyroidism and pulmonary hypertension: an important association","volume":"342","author":"Vallabhajosula","year":"2011","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0230","first-page":"222","article-title":"Pathogenesis of thyroid eye disease-does autoimmunity against the TSH receptor explain all cases?","volume":"61","author":"Wall","year":"2010","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.pnpbp.2016.06.001_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461630080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461630080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T04:20:28Z","timestamp":1600748428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461630080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":47,"alternative-id":["S027858461630080X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of circulating thyroid hormone do not cause the medical sequelae of hyperthyroidism","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}